BBLIX
Price
$16.20
Change
-$0.21 (-1.28%)
Updated
Feb 21 closing price
Net Assets
479.95M
GFACX
Price
$65.66
Change
-$1.58 (-2.35%)
Updated
Feb 21 closing price
Net Assets
304.33B
Ad is loading...

BBLIX vs GFACX

Header iconBBLIX vs GFACX Comparison
Open Charts BBLIX vs GFACXBanner chart's image
BBH Select Series - Large Cap
Price$16.20
Change-$0.21 (-1.28%)
VolumeN/A
Net Assets479.95M
American Funds Growth Fund of Amer C
Price$65.66
Change-$1.58 (-2.35%)
VolumeN/A
Net Assets304.33B
BBLIX vs GFACX Comparison Chart
Loading...
View a ticker or compare two or three
VS
BBLIX vs. GFACX commentary
Feb 23, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is BBLIX is a StrongBuy and GFACX is a Hold.

Ad is loading...
FUNDAMENTALS
Fundamentals
GFACX has more cash in the bank: 304B vs. BBLIX (480M). BBLIX pays higher dividends than GFACX: BBLIX (0.26) vs GFACX (0.00). BBLIX was incepted earlier than GFACX: BBLIX (5 years) vs GFACX (24 years). GFACX is a more actively managed with annual turnover of: 31.00 vs. BBLIX (9.00). GFACX has a lower initial minimum investment than BBLIX: GFACX (250) vs BBLIX (10000). GFACX (10.15) and BBLIX (9.66) have marching annual gain over last year. BBLIX return over 5 years is better than : 52.57 vs. GFACX (32.83).
BBLIXGFACXBBLIX / GFACX
Total Expense RatioN/AN/A-
Annual Report Gross Expense RatioN/AN/A-
Fund Existence5 years24 years-
Gain YTD4.9222.980165%
Front LoadN/AN/A-
Min. Initial Investment100002504,000%
Min. Initial Investment IRAN/AN/A-
Net Assets480M304B0%
Annual Yield % from dividends0.260.00-
Returns for 1 year9.6610.1595%
Returns for 3 years28.8117.69163%
Returns for 5 years52.5732.83160%
Returns for 10 yearsN/A55.63-
View a ticker or compare two or three
Ad is loading...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
HLN10.080.18
+1.82%
Haleon plc
SANM85.72-2.84
-3.21%
Sanmina Corp
HMST9.80-0.33
-3.26%
HomeStreet
ATNM1.17-0.06
-4.88%
Actinium Pharmaceuticals
EVEX4.17-0.33
-7.33%
Eve Holding